CA976899A - Pepsin inhibitory peptides from streptomyces - Google Patents

Pepsin inhibitory peptides from streptomyces

Info

Publication number
CA976899A
CA976899A CA138,010A CA138010A CA976899A CA 976899 A CA976899 A CA 976899A CA 138010 A CA138010 A CA 138010A CA 976899 A CA976899 A CA 976899A
Authority
CA
Canada
Prior art keywords
streptomyces
inhibitory peptides
pepsin
pepsin inhibitory
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA138,010A
Other versions
CA138010S (en
Inventor
Takaaki Aoyagi
Tetsuji Miyano
Kohtaro Funaishi
Tomio Takeuchi
Hamao Umezawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Application granted granted Critical
Publication of CA976899A publication Critical patent/CA976899A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
CA138,010A 1971-03-26 1972-03-24 Pepsin inhibitory peptides from streptomyces Expired CA976899A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1729271A JPS547876B1 (en) 1971-03-26 1971-03-26

Publications (1)

Publication Number Publication Date
CA976899A true CA976899A (en) 1975-10-28

Family

ID=11939901

Family Applications (1)

Application Number Title Priority Date Filing Date
CA138,010A Expired CA976899A (en) 1971-03-26 1972-03-24 Pepsin inhibitory peptides from streptomyces

Country Status (27)

Country Link
JP (1) JPS547876B1 (en)
AT (1) AT316463B (en)
BE (1) BE781253A (en)
BG (2) BG19809A3 (en)
CA (1) CA976899A (en)
CH (1) CH577557A5 (en)
CS (1) CS174828B2 (en)
DE (1) DE2213674C3 (en)
DK (1) DK131792C (en)
EG (1) EG10462A (en)
ES (1) ES400777A1 (en)
FI (1) FI48474C (en)
FR (1) FR2130730B1 (en)
GB (1) GB1394231A (en)
HU (1) HU166530B (en)
IE (1) IE36183B1 (en)
IL (1) IL38954A (en)
LU (1) LU65036A1 (en)
NL (1) NL165501C (en)
NO (1) NO136051C (en)
PH (1) PH10703A (en)
PL (1) PL88968B1 (en)
RO (1) RO62299A (en)
SE (1) SE399909B (en)
SU (1) SU588927A3 (en)
YU (1) YU35274B (en)
ZA (1) ZA721668B (en)

Also Published As

Publication number Publication date
LU65036A1 (en) 1972-07-11
FI48474B (en) 1974-07-01
GB1394231A (en) 1975-05-14
SU588927A3 (en) 1978-01-15
NL7204068A (en) 1972-09-28
BG20616A3 (en) 1975-12-05
ZA721668B (en) 1972-12-27
DK131792C (en) 1976-03-29
HU166530B (en) 1975-03-28
RO62299A (en) 1978-02-15
DE2213674A1 (en) 1972-10-26
CS174828B2 (en) 1977-04-29
BG19809A3 (en) 1975-10-10
NO136051B (en) 1977-04-04
BE781253A (en) 1972-09-25
NO136051C (en) 1977-07-13
IE36183L (en) 1972-09-26
YU35274B (en) 1980-10-31
YU79572A (en) 1980-04-30
ES400777A1 (en) 1975-11-01
FI48474C (en) 1974-10-10
FR2130730A1 (en) 1972-11-03
DE2213674C3 (en) 1978-04-27
DE2213674B2 (en) 1977-09-01
PH10703A (en) 1977-08-24
IL38954A (en) 1974-10-22
FR2130730B1 (en) 1975-03-21
CH577557A5 (en) 1976-07-15
AT316463B (en) 1974-07-10
NL165501C (en) 1981-04-15
IL38954A0 (en) 1972-05-30
PL88968B1 (en) 1976-10-30
JPS547876B1 (en) 1979-04-10
IE36183B1 (en) 1976-09-01
DK131792B (en) 1975-09-01
SE399909B (en) 1978-03-06
EG10462A (en) 1976-11-30

Similar Documents

Publication Publication Date Title
CA964154A (en) Gas-generating valve
CA969261A (en) Time division switching system
AU445513B2 (en) Speech-controlled switching arrangement
AU464407B2 (en) Prisms
CA957076A (en) Speech-controlled switching arrangement
CA986049A (en) Aspiculamycin from streptomyces toyocaensis
CA928238A (en) Pepsin inhibitory peptide from streptomyces
CA983419A (en) Pepsin inhibitors from streptomyces
CA983875A (en) Amylase inhibitor from streptomyces
CA990669A (en) Antibiotic a477 from actinoplanes
AU451583B2 (en) Tuning system
AU463038B2 (en) Improvements inspeech synthesisers
CA986862A (en) Cephalosporin-type antibiotic from streptomyces
AU452594B2 (en) Actuator system
CA986047A (en) Antibiotic a-4696 from actinoplanes
CA976899A (en) Pepsin inhibitory peptides from streptomyces
CA983872A (en) Spectinomycin (actinospectatin) from streptomyces hydroscopicus
CA986863A (en) Cephalosporin-type antibiotic from streptomyces
CA878705A (en) Ignition system
CA950347A (en) Propane-piezoelectric ignition system
AU466276B2 (en) Peptides
CA865760A (en) Peptide derivatives
CA868770A (en) Compressor control system
CA883293A (en) Formamido-containing alkenylsuccinates
CA861487A (en) Fractionation system